Long-term titrated-dose alpha-glucosidase inhibition in non-insulin-requiring Hispanic NIDDM patients

Diabetes Care
P S JohnstonS M Haffner

Abstract

To assess the long-term safety and effectiveness of a titrated dose of the alpha-glucosidase inhibitor miglitol (BAY m 1099) in Hispanic NIDDM patients. A 1-year double-blind randomized placebo-controlled study in which diet-treated or diet plus sulfonylurea-treated Hispanic NIDDM patients received either placebo (n = 131) or miglitol in doses of 50, 100, 150, 200 mg t.i.d. (n = 254), up-titrated and down-titrated based on tolerability. Efficacy parameters included changes from baseline in HbA1c, fasting and 2-h postprandial plasma glucose and serum insulin, fasting serum lipids, and urinary albumin-to-creatinine ratio (ACR). Safety assessments consisted primarily of tabulation of adverse events and intercurrent illnesses, and of periodic laboratory determinations. Reductions from baseline in HbA1c levels at the 6-month (primary efficacy) endpoint were significantly greater by 0.83% in the miglitol group than in the placebo group. HbA1c reductions in the miglitol treatment group significantly exceeded those in the placebo group by 0.63, 0.73, and 0.92% at 3, 9, and 12 months of treatment, respectively. Reductions in 120-min postprandial glucose and insulin levels were significantly greater in the miglitol group than in the plac...Continue Reading

Citations

May 5, 1999·Diabetic Medicine : a Journal of the British Diabetic Association·G RiccardiC Bianchi
Aug 10, 2000·Drugs·J M Chehade, A D Mooradian
Mar 16, 2001·Expert Opinion on Pharmacotherapy·J P SelsB H Wolffenbuttel
Mar 17, 2015·Current Medical Research and Opinion·Keith C Ferdinand, Samar A Nasser
Jan 27, 2000·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·O ChassanyJ F Bergmann
Sep 7, 2000·European Journal of Clinical Investigation·L Monnier
May 26, 2001·Diabetes Care·J L ChiassonUNKNOWN Miglitol Canadian University Investigator Group
Apr 23, 2005·The Cochrane Database of Systematic Reviews·F A Van de LaarC Van Weel
Jan 2, 2001·Endocrine Reviews·S MatthaeiH U Häring
Dec 1, 2000·The Annals of Pharmacotherapy·L K CampbellR K Campbell
Feb 2, 2017·Clinical Diabetes : a Publication of the American Diabetes Association·José E Rodríguez, Kendall M Campbell

❮ Previous
Next ❯

Related Concepts

Related Feeds

American Diabetes Association Journals

Discover the latest diabetes research published by the journals from the American Diabetes Association.

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.